Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Mineralys Therapeutics, Inc. (MLYS).
Alexander Asam, Ph.D., has announced he will step down from the Board of Directors at Mineralys Therapeutics, Inc. upon the expiration of his term, coinciding with the 2024 annual stockholders’ meeting. Asam’s departure is not due to any conflicts with the company’s operations, policies, or practices, ensuring a drama-free transition for investors following the company’s governance.
For an in-depth examination of MLYS stock, go to TipRanks’ Stock Analysis page.